TUMOR-SPECIFIC IMMUNE RESPONSE AFTER PHOTODYNAMIC THERAPY

por Yu. N. Anokhin, E. V. Abakushina
Publicado 2016

POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE

por E. A. Shulenina, E. V. Abakushina, E. Yu. Lyssuk
Publicado 2017

Development of approaches for cellular immunotherapy of cancer patients

por Yu. V. Gelm, E. V. Abakushina, I. A. Pasova, L. Yu. Grivtsova
Publicado 2021

INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN

por E. V. Abakushina, E. Yu. Lyssuk, A. V. Posvyatenko, A. V. Kibardin
Publicado 2017

LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES

por E. V. Abakushina, Yu. V. Marizina, G. S. Neprina, I. A. Pasova, B. A. Berdov
Publicado 2014

LYMPHOCYTE PHENOTYPE IN PATIENTS WITH SKIN MELANOMA AFTER IMMUNOTHERAPY OF ACTIVATED LYMPHOCYTES

por E. V. Abakushina, Yu. V. Marizina, G. S. Neprina, D. V. Kudryavtsev, G. T. Kudryavtseva, N. V. Selivanova
Publicado 2015

CIRCULATING MICA PROTEIN IN PATIENTS WITH MALIGNANT LYMPHOMAS

por A. V. Klinkova, E. G. Kuzmina, E. V. Abakushina, L. M. Kanevskiy, G. S. Neprina, V. V. Pavlov, E. I. Kovalenko
Publicado 2016